As of October 2024 BridgeBio Pharma has a market cap of ยฃ3.36 Billion. This makes BridgeBio Pharma the world's 2970th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 9th, 2024 the market cap of BridgeBio Pharma was reported to be: